Jane Street
NERV icon

Jane Street’s Minerva Neurosciences NERV Stock Holding History

Jane Street’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,365
Closed -$9K – 10781
2021
Q4 		$9K Buy
+1,365
New +$12.9K ﹤0.01% 9914
2021
Q3 		– Sell
-6,480
Closed -$120K – 10451
2021
Q2 		$120K Buy
6,480
+4,594
+244% +$98.9K ﹤0.01% 9180
2021
Q1 		$44K Buy
1,886
+394
+26% +$9.85K ﹤0.01% 8862
2020
Q4 		$28K Buy
+1,492
New +$37.6K ﹤0.01% 7357
2020
Q3 		– Sell
-24,108
Closed -$696K – 7652
2020
Q2 		$696K Buy
+24,108
New +$1.41M ﹤0.01% 4583
2019
Q3 		– Sell
-1,946
Closed -$88K – 5521
2019
Q2 		$88K Buy
+1,946
New +$97.4K ﹤0.01% 4881

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's NERV Position: Q1 2022 in Review

Jane Street sold out of Minerva Neurosciences (NERV) in Q1 2022, closing a stake of 1,365 shares — an estimated $9K sold.

Jane Street first reported a position in NERV in Q2 2019 and held it in 6 quarters. The position peaked at $696K in Q2 2020. 33 funds tracked by Wall St. Rank hold NERV as of Q1 2022.

  • Jane Street reported no remaining Minerva Neurosciences position as of Q1 2022 after selling out during the quarter.
  • Jane Street sold 1,365 Minerva Neurosciences shares in Q1 2022, an estimated $9K.
  • Jane Street first reported a position in Minerva Neurosciences in Q2 2019 and held it in 6 quarters.
  • Jane Street's Minerva Neurosciences position peaked at $696K in Q2 2020.
  • 33 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.